1. Mov Disord Clin Pract. 2021 Sep 3;8(Suppl 1):S21-S23. doi: 10.1002/mdc3.13289.
 eCollection 2021 Aug.

GM1-Gangliosidosis Type III Associated Parkinsonism.

Kaiyrzhanov R(1)(2), Guliyeva U(3), Gulieva S(3), Salayev K(4), Mursalova A(4), 
Allahyarova P(4), Ferla MP(5)(6), Houlden H(1).

Author information:
(1)Department of Neuromuscular Disorders University College London, Institute of 
Neurology London United Kingdom.
(2)Department of Neurology South Kazakhstan Medical Academy Shymkent Kazakhstan.
(3)MediClub Hospital Baku Azerbaijan.
(4)Department of Neurology Azerbaijan Medical University Baku Azerbaijan.
(5)NIHR Oxford BRC Genomic Medicine, Wellcome Centre for Human Genetics 
University of Oxford Oxford United Kingdom.
(6)Structural Genomics Consortium, University of Oxford Oxford United Kingdom.

DOI: 10.1002/mdc3.13289
PMCID: PMC8414511
PMID: 34514040

Conflict of interest statement: This study was funded by the Medical research 
council (MRC) (MR/S01165X/1, MR/S005021/1, G0601943). The authors declare that 
there are no conflicts of interest relevant to this work.